S Bolis
Overview
Explore the profile of S Bolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ladetto M, Tavarozzi R, Zanni M, Evangelista A, Ferrero S, Tucci A, et al.
Ann Oncol
. 2023 Nov;
35(1):118-129.
PMID: 37922989
Background: Optimal consolidation for young patilents with relapsed/refractory (R/R) follicular lymphoma (FL) remains uncertain in the rituximab era, with an unclear benefit of autologous stem cell transplantation (ASCT). The multicenter,...
2.
Burrello J, Biemmi V, Dei Cas M, Amongero M, Bolis S, Lazzarini E, et al.
Sci Rep
. 2020 Oct;
10(1):16182.
PMID: 32999414
Sphingolipids are structural components of cell membrane, displaying several functions in cell signalling. Extracellular vesicles (EV) are lipid bilayer membrane nanoparticle and their lipid composition may be different from parental...
3.
Bolis S, Celebrano M, Ghirardini L, Finazzi M, Botta C, Beeckman J, et al.
Chem Commun (Camb)
. 2015 May;
51(47):9686-9.
PMID: 25977948
By means of confocal photoluminescence measurements and fs pump-probe spectroscopy, we observe the optical properties of phase separation in a mixture of polyfluorene and Liquid Crystals (LCs). The boundaries of...
4.
Rossini F, Pioltelli P, Bolis S, Borin L, Casaroli I, Lanzi E, et al.
Clin Drug Investig
. 2008 Mar;
15(5):425-33.
PMID: 18370498
To assess the economic outcomes produced when a conventional antibiotic treatment regimen requiring three administrations per day was replaced with a treatment regimen requiring only one daily administration, the efficacy,...
5.
Stapleton F, Kasses S, Bolis S, Keay L
Br J Ophthalmol
. 2001 Feb;
85(2):143-6.
PMID: 11159475
Background/aims: Current contact lenses (CLs) when worn on an extended wear basis cause corneal epithelial alterations. The aim of this study was to evaluate changes in corneal epithelial cell morphology...
6.
Lissoni P, Bolis S, Brivio F, Fumagalli L
Anticancer Res
. 2000 Aug;
20(3B):2103-5.
PMID: 10928160
Interleukin-2 (IL-2) has proven to be able to generate an effective anticancer immunity against both solid and hematologic malignancies. Moreover, recent advances in the knowledge of psychoneuroimmunology have demonstrated that...
7.
Lissoni P, Bolis S, Mandala M, Viviani S, Pogliani E, Barni S
Int J Biol Markers
. 1999 Nov;
14(3):167-71.
PMID: 10569139
Tumor necrosis factor-alpha (TNF-alpha), a cytokine provided by both immunomodulating and inflammatory activities, has been described to be abnormally increased in the blood of patients affected by malignant lymphomas, particularly...
8.
Morris C, Holden B, Papas E, Griesser H, Bolis S, Anderton P, et al.
Adv Exp Med Biol
. 1998 Jun;
438:717-22.
PMID: 9634959
No abstract available.
9.
Carrington S, Hicks S, Corfield A, Kaswan R, Packer N, Bolis S, et al.
Adv Exp Med Biol
. 1998 Jun;
438:253-63.
PMID: 9634895
No abstract available.
10.
Molloy M, Bolis S, Herbert B, Ou K, Tyler M, Van Dyk D, et al.
Electrophoresis
. 1998 Mar;
18(15):2811-5.
PMID: 9504814
To understand the changes in protein expression associated with various physiological states as well as the development of pathological eye disease, we have begun to map the protein components of...